Consolidated Statements of Stockholders' Deficit - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Dec. 31, 2024	$ 362	$ 279,354	$ (327,735)	$ (48,019)
Balances (in shares) at Dec. 31, 2024	36,183,067
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings		(14)		(14)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares)	10,412
Stock-based compensation expense		781		781
Net loss			(6,531)	(6,531)
Balances at Mar. 31, 2025	$ 362	280,121	(334,266)	(53,783)
Balances (in shares) at Mar. 31, 2025	36,193,479
Balances at Dec. 31, 2025	$ 364	282,574	(501,534)	(218,596)
Balances (in shares) at Dec. 31, 2025	36,431,444
Exercise of stock options	$ 2	702		$ 704
Exercise of stock options (in shares)	201,708			201,708
2026 Debt and Warrant Amendments		20,640		$ 20,640
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings		(63)		(63)
Issuance of Common Stock upon release of restricted stock units, net of tax withholdings (In shares)	11,551
Stock-based compensation expense		1,075		1,075
Net loss			(115,346)	(115,346)
Balances at Mar. 31, 2026	$ 366	$ 304,928	$ (616,880)	$ (311,586)
Balances (in shares) at Mar. 31, 2026	36,644,703